Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K.   Kucera E.   Zeisler H.   Speiser P.   Reinthaller A.   Sevelda P.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C.   Oliver R.T.D.   Gallagher C.J.   J. O.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

Second-line chemotherapy for advanced gastric cancer in Korea

By Baek Sun   Kim Si-Young   Jeong Jae-heon   Cho Kyung   Yoon Hwi-Joong  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 345-354

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Intraperitoneal Cisplatin Plus Systemic Etoposide as Second-line Treatment in Patients With Small Volume Residual Ovarian Cancer

By de Jong R.S.   Willemse P.H.B.   Boonstra H.   de Vries E.G.E.   van der Graaf W.T.A.   Sleijfer D.T.   van der Zee A.G.J.   Mulder N.H.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite